跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEQEMBI - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LEQEMBI
Authorized
STANDARD
LEQEMBI
EISAI LIMITED
🇨🇦 Health Canada
Approval Date
Feb 6, 2026
Approval ID
615c58cd042eaf41
Company
EISAI LIMITED
Type
Standard
Approval Details
Approval Id
615c58cd042eaf41
Drug Approval Canada Name
LEQEMBI
Product Name
LEQEMBI
Status
Marketed
Status Date
2025-12-16
Original Market Date
2025-12-16
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Schedule D , Prescription
Ahfs
90:10.04
Atc Original
N06DX04 LECANEMAB
Aig Number
0167649001
Company Name
EISAI LIMITED
Company Address
6925 Century Ave, Suite 701 Mississauga Ontario Canada L5N 7K2
Company Detail Path
/organization/eisai-limited
Company Information
Pharmaceutical Company Name
EISAI LIMITED
Country Name
Ireland
Address
TEN EARLSFORT TERRACE
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 6, 2026
Approval ID
615c58cd042eaf41
Type
Standard
Back to Health Canada Approvals